Official name
RU: Аэропортовая больница Онкологического центра Тяньцзиня / Аэропортовый кампус Тяньцзиньского онкологического института и больницы
EN: Tianjin Cancer Hospital Airport Hospital (also: Tianjin Medical University Cancer Institute and Hospital – Airport Free Trade Zone Hospital / Airport Campus)
Country, city, address
Country: China (PRC)
City/Area: Tianjin, Airport Economic Area / Free Trade Zone (Dongli)
Address: No. 99, East 5th Road, Tianjin Airport Economic Area, Tianjin 300308, China
Year of establishment (confirmed)
The Airport Campus was put into use in 2017 (end of 2017).
Type of clinic
Specialized tertiary cancer hospital (branch/campus of Tianjin Medical University Cancer Institute and Hospital — TMUCIH).
Main specializations
The campus is positioned as a precision oncology hub offering:
Surgical oncology (including minimally invasive)
Radiation therapy and nuclear medicine
Systemic therapy (chemotherapy, immunotherapy, targeted therapy)
Hematopoietic stem cell transplantation (auto‑ and allo‑HSCT)
Proton therapy (listed among campus capabilities)
Hematologic malignancies (leukemia, lymphoma, myeloma) and solid tumors across sites.
Key technologies
5D holographic PET/CT (advanced PET/CT system cited for the campus).
Yttrium‑90 resin microspheres (internal radiotherapy).
NanoKnife (interventional ablation).
Precision diagnostics: ARMS‑PCR, flow cytometry, FISH, NGS (various panel sizes).
Transplant infrastructure, including Class‑100 laminar flow VIP wards.
The campus is active in clinical research (e.g., NSCLC, multiple myeloma, HCC, radioligand studies).
Diseases treated
Comprehensive oncology care: lung, GI (stomach, esophagus, colorectal), breast, head & neck, liver (including portal vein tumor thrombus studies), and hematologic cancers (leukemias, lymphomas, myeloma), among others.
International center
Described as an international hub for cancer care; services for overseas patients include expedited visa support, insurance coordination, multilingual case managers, VIP wards, culturally adapted meals, and global post‑treatment follow‑up.
Languages
Not exhaustively listed, but the presence of multilingual case managers indicates at least Chinese and English, with additional languages via interpreters.
Doctors / leading specialists
Public profiles highlight experts in cellular therapy and transplantation, including:
Dr. Bryan Liu (CAR‑T, gene therapy)
Dr. Qian Li (CAR‑T, auto‑HSCT)
Dr. Yafei Wang (hematologic malignancies, transplantation)
Clinical trial records also name TMUCIH investigators (e.g., Li Huikai, MD for an HCC study).
For disease‑specific matching, request the current specialist roster from the campus international office.
Equipment (confirmed)
PET/CT (including advanced 5D holographic system)
Infrastructure for proton therapy (cited in campus capabilities)
Molecular diagnostics platforms (ARMS‑PCR, FISH, NGS) and flow cytometry
Transplant support facilities (Class‑100 laminar flow VIP wards)
Official website
Main cancer center: https://www.tmucih.com/
(campus information is within TMUCIH’s site structure).
Campus overview (international-facing summary): https://www.bioocus.com/cgt-centers/tianjin-cancer-hospital-airport-campus/
Related Chinese‑language site for the airport hospital: https://www.tjkgmuch.com/
The date of the last verification of the information: 06.10.2026.
Oncology
